Viewing Study NCT06793956


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-05-31 @ 10:01 AM
Study NCT ID: NCT06793956
Status: RECRUITING
Last Update Posted: 2025-03-13
First Post: 2025-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extranodal Natural Killer/T Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sintilimab View
None Linperlisib View
None Extranodal Natural Killer/T Cell Lymphoma View